Sinovac gets W.H.O approval | Daily News

Sinovac gets W.H.O approval

The World Health Organization (WHO) has authorized a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for Emergency Use.

The decision will allow CoronaVac to be used in WHO’s vaccine-sharing program, COVAX, which seeks to provide equitable global access to immunizations. It is the second Chinese vaccine to be given WHO authorization after Sinopharm was green lit in early May.

WHO Director-General Tedros Adhanom Ghebreyesus said at a news briefing Tuesday that CoronaVac was “found to be safe, effective, and quality-assured following two doses of the inactivated vaccine.”

WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has recommended the vaccine for people over 18. Two doses should be spaced between two and four weeks.

Unlike some other vaccines, CoronaVac doesn’t need to be kept at super-cold temperatures.

“The easy storage requirements of CoronaVac make it very suitable for low-resource settings,” Tedros said. “It’s now crucial to get these lifesaving tools to the people that need them quickly.”

The World Health Organization (WHO) has authorized a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for Emergency Use.

Efficacy studies showed CoronaVac prevented symptomatic disease in just over half of those vaccinated and prevented severe Covid-19 and hospitalization in 100% of those studied, the WHO said in a statement.

It is the eighth vaccine to receive emergency use listing from WHO, including those from Pfizer/BioNtech, AstraZeneca, Moderna, Janssen (Johnson & Johnson) and the Serum Institute of India.

There is urgent need for COVID-19 vaccines in places where coronavirus is surging and in countries that have been unable to procure sufficient doses.

It is hoped the Sinovac approval will boost supplies of the global vaccine-sharing program COVAX. The program has recently faced a severe shortage of supplies from India, which halted export of the AstraZeneca vaccine amid its Covid-19 crisis. Western countries have also been criticized for vaccine stockpiling.

COVAX should have already delivered 170 million total doses, according to a recent report from the UN Children’s Fund (UNICEF). Instead, as of May 17, it had delivered 71 million shots to 125 countries and territories.

“The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” Mariângela Simão, WHO assistant-director general for access to health products, said in a statement. (CNN)